Cohance Lifesciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cohance Lifesciences has informed the exchanges that a board meeting will be held on November 12, 2025 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ending September 30, 2025. As per SEBI insider trading norms, the trading window for dealing in the company's securities will be closed from October 1, 2025 to November 14, 2025, covering the pre- and post-results period. This is a routine compliance filing and does not itself contain any financial numbers or material business update.
No direct impact on shareholders or stock price from this notice. Investors should watch for the Q2/H1 FY26 results announcement expected on or around November 12, 2025, as that will be the next material update.